Ticker

AXQ Capital LP purchased a new position in Dynavax Technologies Corporation (NASDAQ: DVAX) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 35,615 shares of the biopharmaceutical company's stock, valued at approximately $354,000. Several other large investors also recently bought and

/PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, S&P SmallCap 600: S&P MidCap 400 constituent Ciena Corp

AlphaQuest LLC grew its holdings in Dynavax Technologies Corporation (NASDAQ: DVAX) by 109.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 173,140 shares of the biopharmaceutical company's stock after purchasing an additional 90,641 shares during the period. AlphaQuest LLC

114,000 shares were exercised and sold on Jan. 15, 2026, for a transaction value of approximately ~$1.8 million, at a weighted average price of around $15.64 per share. The entire trade was executed via direct holdings through an option exercise and immediate sale, with no indirect entities involved.

Dynavax Technologies Corporation (NASDAQ: DVAX - Get Free Report) has been assigned a consensus rating of "Hold" from the five ratings firms that are covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating and two have assigned a buy rating to the company.